Prothena | Pasivo Circulante



Current Liabilities Cambio Fecha
Acadia Pharmaceuticals USD 394.87M 50.92M 2024-12
Agios Pharmaceuticals USD 81.16M 38.3M 2024-12
ALKERMES USD 465.2M 11.5M 2024-12
Alnylam Pharmaceuticals USD 1.19B 34.39M 2024-12
Amgen USD 23.1B 2.79B 2024-12
Biogen USD 5.53B 103.8M 2024-12
BioMarin Pharmaceutical USD 606.99M 108.67M 2024-12
Exelixis USD 403.77M 9.42M 2025-01
Incyte USD 1.89B 244.96M 2025-03
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
MacroGenics USD 55.53M 3.78M 2024-12
Neurocrine Biosciences USD 507.7M 78M 2024-12
Prothena USD 48.5M 2.08M 2024-12
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12



Prothena Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.